Japanese patients
Showing 1 - 25 of 4,176
Colonic Tumors Trial in Moscow (Japanese pathological investigation, European pathological investigation)
Not yet recruiting
- Colonic Neoplasms
- Japanese pathological investigation
- European pathological investigation
-
Moscow, Russian FederationClinic of coloproctology and minimally invasive surgery
Nov 1, 2023
Diabetes, Type 2 Trial in Tokyo (NNC0519-0130, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- NNC0519-0130
- Placebo
-
Tokyo, JapanNovo Nordisk Investigational Site
May 12, 2023
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Wilson Disease Trial in London (ALXN1840)
Completed
- Wilson Disease
-
London, United KingdomRichmond Pharmacology Ltd., St George's University of London
Nov 29, 2022
Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)
Not yet recruiting
- Healthy Volunteers
- ABBV-903
- Placebo for ABBV-903
- (no location specified)
Aug 21, 2023
Healthy Trial (BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- (no location specified)
Nov 15, 2023
Healthy Volunteer Study Trial in Cypress (Bemnifosbuvir (BEM))
Completed
- Healthy Volunteer Study
- Bemnifosbuvir (BEM)
-
Cypress, CaliforniaAtea Study Site
Jun 14, 2023
Healthy Trial in Tokyo, Shinjuku-ku (BI 765845, Placebo)
Active, not recruiting
- Healthy
- BI 765845
- Placebo
-
Tokyo, Shinjuku-ku, JapanClinical Research Hospital Tokyo
Nov 15, 2023
Moderate to Severe Glabellar Lines Trial (AGN-151586, Placebo)
Not yet recruiting
- Moderate to Severe Glabellar Lines
- AGN-151586
- Placebo
- (no location specified)
Nov 22, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- Placebo
-
Sumida City, Tokyo, JapanSumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Oct 23, 2023
Obesity Trial in Fukuoka (NNC0487-0111, Placebo (NNC0487-0111))
Recruiting
- Obesity
- NNC0487-0111
- Placebo (NNC0487-0111)
-
Fukuoka, JapanNovo Nordisk Investigational Site
Sep 19, 2023
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
Healthy Participants Trial in Cypress (BMS-986446, Placebo)
Not yet recruiting
- Healthy Participants
- BMS-986446
- Placebo
-
Cypress, CaliforniaAltasciences
Oct 10, 2023
Healthy Participants Trial in Glendale (AZD5055, Placebo)
Not yet recruiting
- Healthy Participants
- AZD5055
- Placebo
-
Glendale, CaliforniaResearch Site
Jul 13, 2023
Healthy Volunteer Trial in Hamilton (Japanese-translated evidence summaries (Advanced Clinical Evidence report from
Completed
- Healthy Volunteer
- Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
- English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
-
Hamilton, Ontario, CanadaMcMaster University
Jul 30, 2022
Healthy Volunteers Trial in City (BMS-986325, Placebo)
Not yet recruiting
- Healthy Volunteers
- BMS-986325
- Placebo
-
City, State, JapanLocal Institution
Apr 3, 2023
Parkinson Disease Trial in Toon (Lu AF28996)
Not yet recruiting
- Parkinson Disease
- Lu AF28996
-
Toon, Ehime, JapanEhime University Hospital
Aug 16, 2023
Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis
- +2 more
- Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
- No prospective interventions
-
Lishui, Zhejiang, China
- +2 more
Nov 13, 2022